Recombinant factor VIIa use in patients presenting with intracranial hemorrhage. [PDF]
Springerplus, 2014 Yampolsky N +4 more
europepmc +1 more source
A Budget Impact Model of Hemophilia Bypassing Agent Prophylaxis Relative to Recombinant Factor VIIa On-Demand. [PDF]
J Manag Care Spec Pharm, 2016 Mehta DA +5 more
europepmc +1 more source
Real-World Early Treatment with Room Temperature-Stable Recombinant Factor VIIa in Hemophilia A/B and Inhibitors: SMART-7™ Post Hoc Analyses. [PDF]
TH Open, 2017 Demartis F +9 more
europepmc +1 more source
Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors. [PDF]
Cochrane Database Syst Rev, 2015 Matino D +4 more
europepmc +1 more source
Rational Use of Recombinant Factor VIIa in Clinical Practice. [PDF]
Indian J Hematol Blood Transfus, 2014 Dutta TK, Verma SP.
europepmc +1 more source
Recombinant factor VIIa addition to haemophilic blood perfused over collagen/tissue factor can sufficiently bypass the factor IXa/VIIIa defect to rescue fibrin generation. [PDF]
Haemophilia, 2017 Li R +4 more
europepmc +1 more source
Recombinant factor VIIa as haemostatic therapy in advanced liver disease. [PDF]
Blood Transfus, 2013 Mannucci PM, Franchini M.
europepmc +1 more source
Use of recombinant factor VIIa in uncontrolled gastrointestinal bleeding after hematopoietic stem cell transplantation among patients with thrombocytopenia. [PDF]
Pak J Med Sci, 2015 Tang Y +7 more
europepmc +1 more source
Evaluation of recombinant factor VIIa treatment for massive hemorrhage in patients with multiple traumas. [PDF]
Ann Lab Med, 2012 Koh YR +6 more
europepmc +1 more source
Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal. [PDF]
World J Emerg Surg, 2014 Chapman SA +6 more
europepmc +1 more source